Work

Data Supplement from PBX1 Is a Favorable Prognostic Biomarker as It Modulates 13-cis Retinoic Acid–Mediated Differentiation in Neuroblastoma

Year: 2023

Type: other

Abstract: Supplementary Methods, including MYCN status of cell lines used, specific Western blot methods, antibodies used and at which concentrations, and primers used in RT-qPCR.

DOI: 10.1158/1078-0432.22447571

Authors: Nilay Shah, Jianjun Wang, Julia Selich-Anderson, Garrett Graham, Hasan Siddiqui, Xin Li, Javed Khan, Jeffrey Toretsky

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361881972

Cites:

Cited by:

Related to: 10